Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Quintiles Digital Properties Win Two Web Marketing Association Awards

Quintiles has received further recognition for the company’s market-leading digital communications with two “Internet Advertising Competition” (IAC) awards: one for its corporate website Quintiles.com and one for its patient education site ClinicalResearch.com. The IAC...

Eyevensys appoints Dr Ivan Cohen-Tanugi as CEO

Eyevensys, a company developing a new non-viral gene therapy process to treat ocular illnesses that enables prolonged production of all therapeutic proteins through electrotransfer, today announces the appointment of Dr Ivan Cohen-Tanugi as CEO.  ...

Med Opportunity Partners, LLC Makes Strategic Investment in Pfanstiehl, Inc.

Med Opportunity Partners LLC (“MEDOP”) a Greenwich CT-based private equity firm focused exclusively on the health care sector announced today its acquisition of Ferro Pfanstiehl Laboratories Inc. a global leader in cGMP carbohydrates and Active Pharmaceutical Ingredients (APIs)...

Innovatix to Exhibit at Inaugural National Association of Specialty Pharmacy Conference

Innovatix LLC the nation’s leading non-acute care group purchasing organization (GPO) will be exhibiting at the inaugural National Association of Specialty Pharmacy (NASP) Conference next week April 2-3 at the Manchester Grand Hyatt in San Diego. ...

Oncodesign signs a partnership agreement and an option for exclusive licensing with Sanofi in the area of tissue protection and repair

Oncodesign, a company specializing in drug discovery and providing pharmacological evaluation services in the field of oncology, today announces that it has signed a second research collaboration agreement with Sanofi.  This partnership follows a...

GLOBAL BIOENERGIES receives 740,000 euros from OSEO to create a pre-industrial strain

Global Bioenergies the industrial biology company that develops sustainable routes to light olefins announces a new 740000 euros financing from OSEO a French SME-funding state agency to support the creation of an isobutene production strain compatible with industrial...

Curie-Cancer trebles early phase clinical research studies with industry partners

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, today announces a strong increase in the number of early stage clinical trials (phase I) from three in 2010 to ten in 2012. The studies are being...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »